Accordingly, in a model of a sustained block of eNOS [149] it is anticipated that PP13 injection may partially reverse the effects of reduced NO signaling and, at least in part, hypertension and reduced uteroplacental perfusion [129]. This evidence concerns the gene LGALS13 and hypertensive disorder.